Source: International Journal of Molecular Medicine. Conference titles: World Congress on Advances in Oncology. Unidades: FM, FMRP
Subjects: GLIOMA, NEOPLASIAS, BIOLOGIA MOLECULAR, BIOLOGIA CELULAR
ABNT
ROSA, José César et al. Quantitative proteomic analysis reveals a molecular triad signature as biomarker candidates for astrocytomas and oligodendrogliomas. International Journal of Molecular Medicine. Athens: Faculdade de Medicina, Universidade de São Paulo. . Acesso em: 08 nov. 2024. , 2013APA
Rosa, J. C., Marie, S. K. N., Oba-Shinjo, S. M., & Gimenez, M. (2013). Quantitative proteomic analysis reveals a molecular triad signature as biomarker candidates for astrocytomas and oligodendrogliomas. International Journal of Molecular Medicine. Athens: Faculdade de Medicina, Universidade de São Paulo.NLM
Rosa JC, Marie SKN, Oba-Shinjo SM, Gimenez M. Quantitative proteomic analysis reveals a molecular triad signature as biomarker candidates for astrocytomas and oligodendrogliomas. International Journal of Molecular Medicine. 2013 ; 32[citado 2024 nov. 08 ]Vancouver
Rosa JC, Marie SKN, Oba-Shinjo SM, Gimenez M. Quantitative proteomic analysis reveals a molecular triad signature as biomarker candidates for astrocytomas and oligodendrogliomas. International Journal of Molecular Medicine. 2013 ; 32[citado 2024 nov. 08 ]